Loading...
Header Logo
Keywords
Last Name
KP Region

Marsha A Raebel, PharmD

TitleSenior Investigator
InstitutionKaiser Permanente Colorado
DepartmentInstitute for Health Research
ORCID ORCID Icon0000-0002-8485-7161 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Marsha A. Raebel, PharmD, is Senior Investigator at the Institute for Health Research. Her research focuses on patient safety, medication adherence, and pharmacoepidemiology, with an emphasis on adverse drug event surveillance and reducing medication and laboratory monitoring errors in the outpatient setting.

    Dr. Raebel completed her doctoral training in pharmacotherapy at the University of Texas Health Sciences Center at San Antonio and the University of Texas at Austin College of Pharmacy. She is nationally-recognized for her foundational research in medication adherence and safety, diabetes, clinical pharmacy, and clinical decision support. She is the coordinating investigator across Kaiser Permanente for the U.S. Food and Drug Administration (FDA) Sentinel initiative and an investigator in the FDA-sponsored Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP) project.

    Dr. Raebel is a Clinical Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and a Fellow of the American College of Clinical Pharmacy.

    Collapse Research 
    Collapse research activities and funding
    1R01HL126125-03     (Bender)Sep 1, 2015 - Aug 31, 2020
    NIH/NHLBI
    The Breathewell Program to Improve Outcomes
    Role: Co-Principal Investigator

         (Lu/Gordon)Jan 1, 2016 - Jun 30, 2019
    Intercept Pharmaceuticals / Henry Ford Health Systems
    FibrOtic Liver Disease Study (FOLD)
    Role: Co-Investigator

    NU47OE000102-01-01     (Raebel)Sep 1, 2016 - Aug 31, 2019
    CDC
    Using a Medical Data Warehouse to Assess Laboratory Quality Improvement Outcomes
    Role: Principal Investigator

    HHSF2232014000421     (Platt)Sep 15, 2016 - Sep 14, 2021
    FDA
    RFTOP Maintenance and Operation for Medication Exposure in Pregnancy Risk Evaluation MEPREP 2
    Role: Co-Principal Investigator

    HHSF22301001T     (Platt)Sep 29, 2016 - Sep 28, 2019
    FDA
    Evaluation of Risk of Neural Tube Defects Among Live Births Exposed to Maternal Prescriptions Opiods During Early Pregnancy
    Role: Co-Principal Investigator

    1R18DK114757-01     (O'Connell)Jul 1, 2017 - Jun 30, 2020
    NIDDK
    Effectiveness of Advanced Practice Pharmacy Services Among American Indian and Alaska Native Adults with Diabetes
    Role: Co-Investigator

    1R01HL136937-01     (Sperl-Hillen)Feb 15, 2018 - Jan 31, 2019
    NHLBI
    Team-Based and Technology Driven Adherence Intervention to Improve Chronic Disease Outcomes
    Role: Co-Investigator

    1R18HS26156-01     (King)Aug 1, 2018 - May 31, 2021
    AHRQ
    Management of Direct Oral Anticoagulants to Lower Adverse Events in Atrial Fibrillation (MODL-AF)
    Role: Co-Principal Investigator

         (Raebel)Sep 1, 2018 - Dec 31, 2018
    Internal
    Direct-to-Patient Outreach to Improve Laboratory Monitoring High-Risk Medications in Ambulatory Care/IVR Lab Outreach
    Role: Principal Investigator

    HHSF2232014000301     (Platt)Sep 22, 2018 - Sep 21, 2019
    FDA
    Sentinel 2014 Infrastructure
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Cottreau CM, Dashevsky I, Andrade SE, Li DK, Nekhlyudov L, Raebel MA, Ritzwoller DP, Partridge AH, Pawloski PA, Toh S. Pregnancy-Associated Cancer: A U.S. Population-Based Study. J Womens Health (Larchmt). 2018 Oct 10. PMID: 30307780.
      View in: PubMed
    2. Nichols GA, Raebel MA, Dyer W, Schmittdiel JA. The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control. J Manag Care Spec Pharm. 2018 Sep; 24(9):856-861. PMID: 30156449.
      View in: PubMed
    3. Smith DH, Shetterly S, Flory J, Haynes K, Lu CY, Gagne JJ, Herrinton L, Nyirenda C, Patorno E, Shoaibi A, Raebel MA. Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2018 Aug; 27(8):872-877. PMID: 29932281.
      View in: PubMed
    4. Raebel MA, Shetterly SM, Goodrich GK, Anderson CB, Shoup JA, Wagner N, Bender BG. Non-response to Communication Technology Outreach for Beta-agonist Overuse in a Pragmatic Randomized Trial of Patients with Asthma. J Gen Intern Med. 2018 06; 33(6):809-811. PMID: 29532303.
      View in: PubMed
    5. Adams AL, Adams JL, Raebel MA, Tang BT, Kuntz JL, Vijayadeva V, McGlynn EA, Gozansky WS. Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study. J Bone Miner Res. 2018 Jul; 33(7):1252-1259. PMID: 29529334.
      View in: PubMed
    6. Lu CY, Penfold RB, Toh S, Sturtevant JL, Madden JM, Simon G, Ahmedani BK, Clarke G, Coleman KJ, Copeland LA, Daida YG, Davis RL, Hunkeler EM, Owen-Smith A, Raebel MA, Rossom R, Soumerai SB, Kulldorff M. Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis. Med Care. 2018 May; 56(5):365-372. PMID: 29634627.
      View in: PubMed
    7. Schroeder EB, Donahoo WT, Goodrich GK, Raebel MA. Validation of an algorithm for identifying type 1 diabetes in adults based on electronic health record data. Pharmacoepidemiol Drug Saf. 2018 Oct; 27(10):1053-1059. PMID: 29292555.
      View in: PubMed
    8. Lu M, Li J, Haller IV, Romanelli RJ, VanWormer JJ, Rodriguez CV, Raebel MA, Boscarino JA, Schmidt MA, Daida YG, Sahota A, Vincent J, Bowlus CL, Lindor K, Rupp LB, Gordon SC. Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems. Clin Gastroenterol Hepatol. 2018 Aug; 16(8):1333-1341.e6. PMID: 29066370.
      View in: PubMed
    9. Raebel MA, Dyer W, Nichols GA, Goodrich GK, Schmittdiel JA. Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes. Pharmacotherapy. 2017 Oct; 37(10):1204-1214. PMID: 28752555.
      View in: PubMed
    10. Mazor KM, Richards A, Gallagher M, Arterburn DE, Raebel MA, Nowell WB, Curtis JR, Paolino AR, Toh S. Stakeholders' views on data sharing in multicenter studies. J Comp Eff Res. 2017 Sep; 6(6):537-547. PMID: 28805448.
      View in: PubMed
    11. Raebel MA, Zeng C, Cheetham TC, Smith DH, Feigelson HS, Carroll NM, Goddard K, Tavel HM, Boudreau DM, Shetterly S, Xu S. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women. Am J Epidemiol. 2017 02 15; 185(4):264-273. PMID: 28186527.
      View in: PubMed
    12. Patorno E, Gagne JJ, Lu CY, Haynes K, Sterrett AT, Roy J, Wang X, Raebel MA. The Role of Hemoglobin Laboratory Test Results for the Detection of Upper Gastrointestinal Bleeding Outcomes Resulting from the Use of Medications in Observational Studies. Drug Saf. 2017 01; 40(1):91-100. PMID: 27848201.
      View in: PubMed
    13. Flory JH, Roy J, Gagne JJ, Haynes K, Herrinton L, Lu C, Patorno E, Shoaibi A, Raebel MA. Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk. J Comp Eff Res. 2017 Jan; 6(1):25-32. PMID: 27935320.
      View in: PubMed
    14. Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Patorno E, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf. 2016 07; 25(7):798-814. PMID: 27146273.
      View in: PubMed
    15. Xu S, Shetterly S, Cook AJ, Raebel MA, Goonesekera S, Shoaibi A, Roy J, Fireman B. Evaluation of propensity scores, disease risk scores, and regression in confounder adjustment for the safety of emerging treatment with group sequential monitoring. Pharmacoepidemiol Drug Saf. 2016 Apr; 25(4):453-61. PMID: 26875591; PMCID: PMC4930363 [Available on 04/01/17].
    16. Lafata JE, Karter AJ, O'Connor PJ, Morris H, Schmittdiel JA, Ratliff S, Newton KM, Raebel MA, Pathak RD, Thomas A, Butler MG, Reynolds K, Waitzfelder B, Steiner JF. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. J Gen Intern Med. 2016 Feb; 31(2):188-95. PMID: 26282954; PMCID: PMC4720651 [Available on 02/01/17].
    17. Hansen C, Andrade SE, Freiman H, Dublin S, Haffenreffer K, Cooper WO, Cheetham TC, Toh S, Li DK, Raebel MA, Kuntz JL, Perrin N, Rosales AG, Carter S, Pawloski PA, Maloney EM, Graham DJ, Sahin L, Scott PE, Yap J, Davis R. Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies. Pharmacoepidemiol Drug Saf. 2016 Feb; 25(2):170-8. PMID: 26599424; PMCID: PMC4772767 [Available on 02/01/17].
    18. Davis RL, Gallagher MA, Asgari MM, Eide MJ, Margolis DJ, Macy E, Burmester JK, Selvam N, Boscarino JA, Cromwell LF, Feigelson HS, Kuntz JL, Pawloski PA, Penfold RB, Raebel MA, Sridhar G, Wu A, La Grenade LA, Pacanowski MA, Pinheiro SP. Identification of Stevens-Johnson syndrome and toxic epidermal necrolysis in electronic health record databases. Pharmacoepidemiol Drug Saf. 2015 Jul; 24(7):684-92. PMID: 25914229.
      View in: PubMed
    19. Schroeder EB, Powers JD, O'Connor PJ, Nichols GA, Xu S, Desai JR, Karter AJ, Morales LS, Newton KM, Pathak RD, Vazquez-Benitez G, Raebel MA, Butler MG, Lafata JE, Reynolds K, Thomas A, Waitzfelder BE, Steiner JF. Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011. J Diabetes Complications. 2015 Jul; 29(5):637-43. PMID: 25936953.
      View in: PubMed
    20. Schmittdiel JA, Nichols GA, Dyer W, Steiner JF, Karter AJ, Raebel MA. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7. PMID: 25719517; PMCID: PMC4359632.
    21. Baldziki M, Brown J, Chan H, Cheetham TC, Conn T, Daniel GW, Hendrickson M, Hilbrich L, Johnson A, Miller SB, Moore T, Motheral B, Priddy SA, Raebel MA, Randhawa G, Surratt P, Walraven C, White TJ, Bruns K, Carden MJ, Dragovich C, Eichelberger B, Rosato E, Sega T. Utilizing data consortia to monitor safety and effectiveness of biosimilars and their innovator products. J Manag Care Spec Pharm. 2015 Jan; 21(1):23-34. PMID: 25562770.
      View in: PubMed
    22. Nichols GA, Schroeder EB, Karter AJ, Gregg EW, Desai J, Lawrence JM, O'Connor PJ, Xu S, Newton KM, Raebel MA, Pathak RD, Waitzfelder B, Segal J, Lafata JE, Butler MG, Kirchner HL, Thomas A, Steiner JF. Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project. Am J Epidemiol. 2015 Jan 01; 181(1):32-9. PMID: 25515167; PMCID: PMC4288120.
    23. Schmittdiel J, Raebel M, Dyer W, Steiner J, Goodrich G, Karter A, Nichols G. Medicare Star excludes diabetes patients with poor CVD risk factor control. Am J Manag Care. 2014 Dec 01; 20(12):e573-81. PMID: 25741874; PMCID: PMC4641517.
    24. Schmittdiel J, Raebel M, Dyer W, Steiner J, Goodrich G, Karter A, Nichols G. Medicare Star excludes diabetes patients with poor CVD risk factor control. Am J Manag Care. 2014 Dec; 20(12):e581-9. PMID: 25665192.
      View in: PubMed
    25. Li DK, Raebel MA, Cheetham TC, Hansen C, Avalos L, Chen H, Davis R. Genital herpes and its treatment in relation to preterm delivery. Am J Epidemiol. 2014 Dec 01; 180(11):1109-17. PMID: 25392064.
      View in: PubMed
    26. Kuntz JL, Johnson ES, Raebel MA, Platt RW, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH. Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score. Clin Microbiol Infect. 2015 Mar; 21(3):256-62. PMID: 25658533.
      View in: PubMed
    27. Dublin S, Johnson KE, Walker RL, Avalos LA, Andrade SE, Beaton SJ, Davis RL, Herrinton LJ, Pawloski PA, Raebel MA, Smith DH, Toh S, Caughey AB. Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt). 2014 Nov; 23(11):904-11. PMID: 25330378; PMCID: PMC4235981.
    28. O'Connor PJ, Schmittdiel JA, Pathak RD, Harris RI, Newton KM, Ohnsorg KA, Heisler M, Sterrett AT, Xu S, Dyer WT, Raebel MA, Thomas A, Schroeder EB, Desai JR, Steiner JF. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care. 2014 Dec; 37(12):3317-24. PMID: 25315207; PMCID: PMC4751474.
    29. Raebel MA, Penfold R, McMahon AW, Reichman M, Shetterly S, Goodrich G, Andrade S, Correll CU, Gerhard T. Adherence to guidelines for glucose assessment in starting second-generation antipsychotics. Pediatrics. 2014 Nov; 134(5):e1308-14. PMID: 25287454.
      View in: PubMed
    30. Schroeder EB, Goodrich GK, Newton KM, Schmittdiel JA, Raebel MA. Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies. J Comp Eff Res. 2014 Jul; 3(4):359-69. PMID: 25275233.
      View in: PubMed
    31. Schmittdiel JA, Raebel MA, Dyer W, Xu S, Goodrich GK, Schroeder EB, Segal JB, O' Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Karter AJ, Lafata JE, Butler MG, Steiner JF. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014 Jul-Aug; 54(4):374-82. PMID: 24860866; PMCID: PMC4161641.
    32. Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, Simon G, Ahmedani BK, Clarke G, Hunkeler EM, Waitzfelder B, Owen-Smith A, Raebel MA, Rossom R, Coleman KJ, Copeland LA, Soumerai SB. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. BMJ. 2014 Jun 18; 348:g3596. PMID: 24942789; PMCID: PMC4062705.
    33. Raebel MA, Newcomer SR, Bayliss EA, Boudreau D, DeBar L, Elliott TE, Ahmed AT, Pawloski PA, Fisher D, Toh S, Donahoo WT. Chronic opioid use emerging after bariatric surgery. Pharmacoepidemiol Drug Saf. 2014 Dec; 23(12):1247-57. PMID: 24733580.
      View in: PubMed
    34. Holmes JH, Elliott TE, Brown JS, Raebel MA, Davidson A, Nelson AF, Chung A, La Chance P, Steiner JF. Clinical research data warehouse governance for distributed research networks in the USA: a systematic review of the literature. J Am Med Inform Assoc. 2014 Jul-Aug; 21(4):730-6. PMID: 24682495; PMCID: PMC4078282.
    35. Raebel MA, Ellis JL, Schroeder EB, Xu S, O'Connor PJ, Segal JB, Butler MG, Schmittdiel JA, Kirchner HL, Goodrich GK, Lawrence JM, Nichols GA, Newton KM, Pathak RD, Steiner JF. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study. Pharmacoepidemiol Drug Saf. 2014 Jul; 23(7):699-710. PMID: 24639086.
      View in: PubMed
    36. Xu S, Shetterly S, Raebel MA, Ho PM, Tsai TT, Magid D. Estimating the effects of time-varying exposures in observational studies using Cox models with stabilized weights adjustment. Pharmacoepidemiol Drug Saf. 2014 Aug; 23(8):812-8. PMID: 24596337; PMCID: PMC4351798.
    37. Raebel MA, Haynes K, Woodworth TS, Saylor G, Cavagnaro E, Coughlin KO, Curtis LH, Weiner MG, Archdeacon P, Brown JS. Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):609-18. PMID: 24677577.
      View in: PubMed
    38. Vaz LE, Kleinman KP, Raebel MA, Nordin JD, Lakoma MD, Dutta-Linn MM, Finkelstein JA. Recent trends in outpatient antibiotic use in children. Pediatrics. 2014 Mar; 133(3):375-85. PMID: 24488744; PMCID: PMC3934343.
    39. McGinnis B, Kauffman Y, Olson KL, Witt DM, Raebel MA. Interventions aimed at improving performance on medication adherence metrics. Int J Clin Pharm. 2014 Feb; 36(1):20-5. PMID: 24287662.
      View in: PubMed
    40. Avalos LA, Chen H, Yang C, Andrade SE, Cooper WO, Cheetham CT, Davis RL, Dublin S, Hammad TA, Kaplan S, Pawloski PA, Raebel MA, Scott PE, Smith DH, Toh S, Li DK. The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007. Matern Child Health J. 2014 Jan; 18(1):64-72. PMID: 23420306; PMCID: PMC3776000.
    41. McClure DL, Raebel MA, Yih WK, Shoaibi A, Mullersman JE, Anderson-Smits C, Glanz JM. Mini-Sentinel methods: framework for assessment of positive results from signal refinement. Pharmacoepidemiol Drug Saf. 2014 Jan; 23(1):3-8. PMID: 24395545.
      View in: PubMed
    42. Raebel MA, Newcomer SR, Reifler LM, Boudreau D, Elliott TE, DeBar L, Ahmed A, Pawloski PA, Fisher D, Donahoo WT, Bayliss EA. Chronic use of opioid medications before and after bariatric surgery. JAMA. 2013 Oct 02; 310(13):1369-76. PMID: 24084922.
      View in: PubMed
    43. Raebel MA, Xu S, Goodrich GK, Schroeder EB, Schmittdiel JA, Segal JB, O'Connor PJ, Nichols GA, Lawrence JM, Kirchner HL, Elston Lafata J, Butler M, Newton KM, Steiner JF. Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study. Ann Pharmacother. 2013 Oct; 47(10):1280-91. PMID: 24259692.
      View in: PubMed
    44. Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013 Aug; 51(8 Suppl 3):S11-21. PMID: 23774515; PMCID: PMC3727405.
    45. Neugebauer R, Fireman B, Roy JA, Raebel MA, Nichols GA, O'Connor PJ. Super learning to hedge against incorrect inference from arbitrary parametric assumptions in marginal structural modeling. J Clin Epidemiol. 2013 Aug; 66(8 Suppl):S99-109. PMID: 23849160; PMCID: PMC3713501.
    46. Toh S, Baker MA, Brown JS, Kornegay C, Platt R. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13; 173(9):817-9. PMID: 23529063.
      View in: PubMed
    47. Johnson KE, Beaton SJ, Andrade SE, Cheetham TC, Scott PE, Hammad TA, Dashevsky I, Cooper WO, Davis RL, Pawloski PA, Raebel MA, Smith DH, Toh S, Li DK, Haffenreffer K, Dublin S. Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf. 2013 Jul; 22(7):776-82. PMID: 23596095; PMCID: PMC3707923.
    48. Kulldorff M, Dashevsky I, Avery TR, Chan AK, Davis RL, Graham D, Platt R, Andrade SE, Boudreau D, Gunter MJ, Herrinton LJ, Pawloski PA, Raebel MA, Roblin D, Brown JS. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):517-23. PMID: 23512870.
      View in: PubMed
    49. Brown JS, Petronis KR, Bate A, Zhang F, Dashevsky I, Kulldorff M, Avery TR, Davis RL, Chan KA, Andrade SE, Boudreau D, Gunter MJ, Herrinton L, Pawloski PA, Raebel MA, Roblin D, Smith D, Reynolds R. Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic. Pharmaceutics. 2013 Mar 14; 5(1):179-200. PMID: 24300404; PMCID: PMC3834945.
    50. Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, Hammad TA, Li DK, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Bobo WV, Lawrence JM, Dashevsky I, Haffenreffer K, Avalos LA, Andrade SE. Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013 Apr; 16(2):149-57. PMID: 23389622; PMCID: PMC3715880.
    51. Herrinton LJ, Harrold LR, Liu L, Raebel MA, Taharka A, Winthrop KL, Solomon DH, Curtis JR, Lewis JD, Saag KG. Association between anti-TNF-a therapy and interstitial lung disease. Pharmacoepidemiol Drug Saf. 2013 Apr; 22(4):394-402. PMID: 23359391; PMCID: PMC3618622.
    52. Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Dashevsky I, Haffenreffer K, Johnson KE, Toh S. Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):524-32. PMID: 23335117; PMCID: PMC3644383.
    53. Lawrence JM, Andrade SE, Avalos LA, Beaton SJ, Chiu VY, Davis RL, Dublin S, Pawloski PA, Raebel MA, Smith DH, Toh S, Wang JQ, Kaplan S, Amini T, Hampp C, Hammad TA, Scott PE, Cheetham TC. Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol. 2013 Jan; 121(1):106-14. PMID: 23262934; PMCID: PMC3811068.
    54. Herrinton LJ, Liu L, Chen L, Harrold LR, Raebel MA, Curtis JR, Griffin MR, Solomon DH, Saag KG, Lewis JD. Association between anti-TNF-a therapy and all-cause mortality. Pharmacoepidemiol Drug Saf. 2012 Dec; 21(12):1311-20. PMID: 23065964; PMCID: PMC3565563.
    55. Andrade SE, Davis RL, Cheetham TC, Cooper WO, Li DK, Amini T, Beaton SJ, Dublin S, Hammad TA, Pawloski PA, Raebel MA, Smith DH, Staffa JA, Toh S, Dashevsky I, Haffenreffer K, Lane K, Platt R, Scott PE. Medication Exposure in Pregnancy Risk Evaluation Program. Matern Child Health J. 2012 Oct; 16(7):1349-54. PMID: 22002179; PMCID: PMC3361624.
    56. Kuntz JL, Johnson ES, Raebel MA, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH. Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Infect Control Hosp Epidemiol. 2012 Oct; 33(10):1031-8. PMID: 22961023.
      View in: PubMed
    57. Hansen C, Desai S, Bredfeldt C, Cheetham C, Gallagher M, Li DK, Raebel MA, Riedlinger K, Shay DK, Thompson M, Davis RL. A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates. J Infect Dis. 2012 Oct; 206(8):1260-8. PMID: 22859826.
      View in: PubMed
    58. Andrade SE, Scott PE, Davis RL, Li DK, Getahun D, Cheetham TC, Raebel MA, Toh S, Dublin S, Pawloski PA, Hammad TA, Beaton SJ, Smith DH, Dashevsky I, Haffenreffer K, Cooper WO. Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf. 2013 Jan; 22(1):7-15. PMID: 22753079; PMCID: PMC3492503.
    59. Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012 Jul; 50 Suppl:S21-9. PMID: 22692254; PMCID: PMC3833692.
    60. Nichols GA, Desai J, Elston Lafata J, Lawrence JM, O'Connor PJ, Pathak RD, Raebel MA, Reid RJ, Selby JV, Silverman BG, Steiner JF, Stewart WF, Vupputuri S, Waitzfelder B. Construction of a multisite DataLink using electronic health records for the identification, surveillance, prevention, and management of diabetes mellitus: the SUPREME-DM project. Prev Chronic Dis. 2012; 9:E110. PMID: 22677160; PMCID: PMC3457753.
    61. Kuntz JL, Johnson ES, Raebel MA, Petrik AF, Yang X, Thorp ML, Spindel SJ, Neil N, Smith DH. Clostridium difficile infection, Colorado and the northwestern United States, 2007. Emerg Infect Dis. 2012 Jun; 18(6):960-2. PMID: 22608207; PMCID: PMC3358157.
    62. Curtis LH, Weiner MG, Boudreau DM, Cooper WO, Daniel GW, Nair VP, Raebel MA, Beaulieu NU, Rosofsky R, Woodworth TS, Brown JS. Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:23-31. PMID: 22262590.
      View in: PubMed
    63. Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, Andrade SE, Pawloski PA, Raebel MA, Smith DH, Achacoso N, Uratsu C, Go AS, Sidney S, Nguyen-Huynh MN, Ray WA, Selby JV. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA. 2011 Dec 28; 306(24):2673-83. PMID: 22161946; PMCID: PMC3350308.
    64. Satterwhite CL, Yu O, Raebel MA, Berman S, Howards PP, Weinstock H, Kleinbaum D, Scholes D. Detection of pelvic inflammatory disease: development of an automated case-finding algorithm using administrative data. Infect Dis Obstet Gynecol. 2011; 2011:428351. PMID: 22144849; PMCID: PMC3226320.
    65. Boudreau DM, Yu O, Gray SL, Raebel MA, Johnson J, Larson EB. Concomitant use of cholinesterase inhibitors and anticholinergics: prevalence and outcomes. J Am Geriatr Soc. 2011 Nov; 59(11):2069-76. PMID: 22091958.
      View in: PubMed
    66. Xu S, Shetterly S, Powers D, Raebel MA, Tsai TT, Ho PM, Magid D. Extension of Kaplan-Meier methods in observational studies with time-varying treatment. Value Health. 2012 Jan; 15(1):167-74. PMID: 22264985; PMCID: PMC3267428.
    67. Scholes D, Yu O, Raebel MA, Trabert B, Holt VL. Improving automated case finding for ectopic pregnancy using a classification algorithm. Hum Reprod. 2011 Nov; 26(11):3163-8. PMID: 21911435; PMCID: PMC3196880.
    68. Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, Shetterly S, Xu S, Steiner JF. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012 Jan; 27(1):57-64. PMID: 21879374; PMCID: PMC3250550.
    69. Andrade SE, Moore Simas TA, Boudreau D, Raebel MA, Toh S, Syat B, Dashevsky I, Platt R. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy. Pharmacoepidemiol Drug Saf. 2011 Nov; 20(11):1168-76. PMID: 22020902.
      View in: PubMed
    70. Tjia J, Fischer SH, Raebel MA, Peterson D, Zhao Y, Gagne SJ, Gurwitz JH, Field TS. Baseline and follow-up laboratory monitoring of cardiovascular medications. Ann Pharmacother. 2011 Sep; 45(9):1077-84. PMID: 21852593.
      View in: PubMed
    71. Raebel MA, Carroll NM, Ellis JL, Schroeder EB, Bayliss EA. Importance of including early nonadherence in estimations of medication adherence. Ann Pharmacother. 2011 Sep; 45(9):1053-60. PMID: 21852598.
      View in: PubMed
    72. Carroll NM, Ellis JL, Luckett CF, Raebel MA. Improving the validity of determining medication adherence from electronic health record medications orders. J Am Med Inform Assoc. 2011 Sep-Oct; 18(5):717-20. PMID: 21613641; PMCID: PMC3168310.
    73. Bhardwaja B, Carroll NM, Raebel MA, Chester EA, Korner EJ, Rocho BE, Brand DW, Magid DJ. Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) program. Pharmacotherapy. 2011 Apr; 31(4):346-56. PMID: 21449624.
      View in: PubMed
    74. Smith DH, Raebel MA, Chan KA, Johnson ES, Petrik AF, Weiss JR, Yang X, Feldstein A. An economic evaluation of a laboratory monitoring program for renin-angiotensin system agents. Med Decis Making. 2011 Mar-Apr; 31(2):315-24. PMID: 21393563.
      View in: PubMed
    75. Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther. 2012 Jun; 30(3):e156-66. PMID: 21883995.
      View in: PubMed
    76. Davis RL, Eastman D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Dublin S, Platt R. Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):138-45. PMID: 21254284; PMCID: PMC3232183.
    77. Raebel MA, Smith ML, Saylor G, Wright LA, Cheetham C, Blanchette CM, Xu S. The positive predictive value of a hyperkalemia diagnosis in automated health care data. Pharmacoepidemiol Drug Saf. 2010 Nov; 19(11):1204-8. PMID: 20878650; PMCID: PMC2996391.
    78. Tjia J, Field TS, Garber LD, Donovan JL, Kanaan AO, Raebel MA, Zhao Y, Fuller JC, Gagne SJ, Fischer SH, Gurwitz JH. Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting. Am J Manag Care. 2010 Jul; 16(7):489-96. PMID: 20645664.
      View in: PubMed
    79. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, Montes de Oca R, Shea YR, Seitz AE, Holland SM, Olivier KN. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010 Oct 01; 182(7):970-6. PMID: 20538958; PMCID: PMC2970866.
    80. Bayliss EA, Ellis JL, Delate T, Steiner JF, Raebel MA. Characteristics of Medicare Part D beneficiaries who reach the drug benefit threshold in both of the first two years of the Part D benefit. Med Care. 2010 Mar; 48(3):267-72. PMID: 20125044.
      View in: PubMed
    81. Raebel MA, Ross C, Xu S, Roblin DW, Cheetham C, Blanchette CM, Saylor G, Smith DH. Diabetes and drug-associated hyperkalemia: effect of potassium monitoring. J Gen Intern Med. 2010 Apr; 25(4):326-33. PMID: 20087674; PMCID: PMC2842549.
    82. Harrold LR, Andrade SE, Briesacher B, Raebel MA, Fouayzi H, Yood RA, Ockene IS. The dynamics of chronic gout treatment: medication gaps and return to therapy. Am J Med. 2010 Jan; 123(1):54-9. PMID: 20102992; PMCID: PMC2813203.
    83. Raebel MA, Ross C, Cheetham C, Petersen H, Saylor G, Smith DH, Wright LA, Roblin DW, Xu S. Increasingly restrictive definitions of hyperkalemia outcomes in a database study: effect on incidence estimates. Pharmacoepidemiol Drug Saf. 2010 Jan; 19(1):19-25. PMID: 19937982.
      View in: PubMed
    84. Price DW, Raebel MA, Conner DA, Wright LA, Carroll NM. Pharmaceuticals from development to practice: learnings from an online curriculum. Am J Manag Care. 2009 Dec 01; 15(12):e109-14. PMID: 19954269.
      View in: PubMed
    85. Malone DC, Boudreau DM, Nichols GA, Raebel MA, Fishman PA, Feldstein AC, Ben-Joseph RH, Okamoto LJ, Boscoe AN, Magid DJ. Association of cardiometabolic risk factors and prevalent cardiovascular events. Metab Syndr Relat Disord. 2009 Dec; 7(6):585-93. PMID: 19900158.
      View in: PubMed
    86. Xu S, Ross C, Raebel MA, Shetterly S, Blanchette C, Smith D. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health. 2010 Mar-Apr; 13(2):273-7. PMID: 19912596; PMCID: PMC4351790.
    87. Boudreau DM, Malone DC, Raebel MA, Fishman PA, Nichols GA, Feldstein AC, Boscoe AN, Ben-Joseph RH, Magid DJ, Okamoto LJ. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord. 2009 Aug; 7(4):305-14. PMID: 19558267.
      View in: PubMed
    88. Mazor KM, Sabin JE, Goff SL, Smith DH, Rolnick S, Roblin D, Raebel MA, Herrinton LJ, Gurwitz JH, Boudreau D, Meterko V, Dodd KS, Platt R. Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf. 2009 Jul; 18(7):554-61. PMID: 19402030.
      View in: PubMed
    89. Smith DH, Feldstein AC, Perrin NA, Yang X, Rix MM, Raebel MA, Magid DJ, Simon SR, Soumerai SB. Improving laboratory monitoring of medications: an economic analysis alongside a clinical trial. Am J Manag Care. 2009 May; 15(5):281-9. PMID: 19435396.
      View in: PubMed
    90. Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, Ockene IS. Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther. 2009; 11(2):R46. PMID: 19327147; PMCID: PMC2688196.
    91. Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf. 2009 Mar; 18(3):226-34. PMID: 19148879.
      View in: PubMed
    92. Andrade SE, McPhillips H, Loren D, Raebel MA, Lane K, Livingston J, Boudreau DM, Smith DH, Davis RL, Willy ME, Platt R. Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 2009 Mar; 18(3):246-52. PMID: 19148882.
      View in: PubMed
    93. Hartsfield CL, Korner EJ, Ellis JL, Raebel MA, Merenich J, Brandenburg N. Painful diabetic peripheral neuropathy in a managed care setting: patient identification, prevalence estimates, and pharmacy utilization patterns. Popul Health Manag. 2008 Dec; 11(6):317-28. PMID: 19108647.
      View in: PubMed
    94. Raebel MA, Delate T, Ellis JL, Bayliss EA. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D. Med Care. 2008 Oct; 46(10):1116-22. PMID: 18815534.
      View in: PubMed
    95. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Dal Pan GJ, Scott PE, Platt R. Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf. 2008 Mar; 17(3):240-7. PMID: 18200619.
      View in: PubMed
    96. Price DW, Raebel MA, Conner DA, Wright LA. Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed Drugs. Perm J. 2008; 12(2):28-35. PMID: 21364809; PMCID: PMC3042287.
    97. Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1275-84. PMID: 17955500.
      View in: PubMed
    98. Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf. 2007 Oct; 16(10):1086-94. PMID: 17729378.
      View in: PubMed
    99. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, Staffa JA, Platt R. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008 Feb; 198(2):194.e1-5. PMID: 17905176.
      View in: PubMed
    100. Mazor KM, Sabin JE, Boudreau D, Goodman MJ, Gurwitz JH, Herrinton LJ, Raebel MA, Roblin D, Smith DH, Meterko V, Platt R. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care. 2007 Oct; 45(10 Supl 2):S29-37. PMID: 17909379.
      View in: PubMed
    101. Raebel MA, Charles J, Dugan J, Carroll NM, Korner EJ, Brand DW, Magid DJ. Randomized trial to improve prescribing safety in ambulatory elderly patients. J Am Geriatr Soc. 2007 Jul; 55(7):977-85. PMID: 17608868.
      View in: PubMed
    102. Elston Lafata J, Simpkins J, Kaatz S, Horn JR, Raebel MA, Schultz L, Smith DH, Yood MU. What do medical records tell us about potentially harmful co-prescribing? Jt Comm J Qual Patient Saf. 2007 Jul; 33(7):395-400. PMID: 17711141.
      View in: PubMed
    103. Raebel MA, Carroll NM, Kelleher JA, Chester EA, Berga S, Magid DJ. Randomized trial to improve prescribing safety during pregnancy. J Am Med Inform Assoc. 2007 Jul-Aug; 14(4):440-50. PMID: 17460126; PMCID: PMC2244894.
    104. Harrold LR, Saag KG, Yood RA, Mikuls TR, Andrade SE, Fouayzi H, Davis J, Chan KA, Raebel MA, Von Worley A, Platt R. Validity of gout diagnoses in administrative data. Arthritis Rheum. 2007 Feb 15; 57(1):103-8. PMID: 17266097.
      View in: PubMed
    105. Raebel MA, McClure DL, Chan KA, Simon SR, Feldstein AC, Lafata JE, Andrade SE, Gunter MJ, Nelson WW, Roblin D, Platt R. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia? Ann Pharmacother. 2007 Feb; 41(2):193-200. PMID: 17284506.
      View in: PubMed
    106. Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf. 2007 Jan; 16(1):55-64. PMID: 16470693.
      View in: PubMed
    107. Raebel MA, Carroll NM, Simon SR, Andrade SE, Feldstein AC, Lafata JE, Nelson WW, Chan KA, Gunter MJ, Tolsma D, Platt R. Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm. 2006 Oct; 12(8):656-64. PMID: 17269844.
      View in: PubMed
    108. Feldstein AC, Smith DH, Perrin N, Yang X, Rix M, Raebel MA, Magid DJ, Simon SR, Soumerai SB. Improved therapeutic monitoring with several interventions: a randomized trial. Arch Intern Med. 2006 Sep 25; 166(17):1848-54. PMID: 17000941.
      View in: PubMed
    109. Andrade SE, Raebel MA, Morse AN, Davis RL, Chan KA, Finkelstein JA, Fortman KK, McPhillips H, Roblin D, Smith DH, Yood MU, Platt R, H Gurwitz J. Use of prescription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf. 2006 Aug; 15(8):546-54. PMID: 16586470.
      View in: PubMed
    110. Palen TE, Raebel M, Lyons E, Magid DM. Evaluation of laboratory monitoring alerts within a computerized physician order entry system for medication orders. Am J Manag Care. 2006 Jul; 12(7):389-95. PMID: 16834525.
      View in: PubMed
    111. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006 Jul-Aug; 40(7-8):1280-88. PMID: 16868217.
      View in: PubMed
    112. Lafata JE, Schultz L, Simpkins J, Chan KA, Horn JR, Kaatz S, Long C, Platt R, Raebel MA, Smith DH, Xi H, Yood MU. Potential drug-drug interactions in the outpatient setting. Med Care. 2006 Jun; 44(6):534-41. PMID: 16708002.
      View in: PubMed
    113. Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):369-86. PMID: 16294363.
      View in: PubMed
    114. Allen LaPointe NM, Curtis LH, Chan KA, Kramer JM, Lafata JE, Gurwitz JH, Raebel MA, Platt R. Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf. 2006 Jun; 15(6):361-8. PMID: 16178046.
      View in: PubMed
    115. Raebel MA, Carroll NM, Andrade SE, Chester EA, Lafata JE, Feldstein A, Gunter MJ, Nelson WW, Simon SR, Chan KA, Davis RL, Platt R. Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care. 2006 May; 12(5):268-74. PMID: 16686584.
      View in: PubMed
    116. Raebel MA, Chester EA, Newsom EE, Lyons EE, Kelleher JA, Long C, Miller C, Magid DJ. Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients. Pharmacotherapy. 2006 May; 26(5):619-26. PMID: 16637791.
      View in: PubMed
    117. Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG. Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis. 2006 Oct; 65(10):1368-72. PMID: 16644784; PMCID: PMC1798311.
    118. Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein AC, Gunter MJ, Lafata JE, Harrold L, Nelson WW, Platt R. Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients. Ann Pharmacother. 2006 Mar; 40(3):386-91. PMID: 16478808.
      View in: PubMed
    119. Simon SR, Andrade SE, Ellis JL, Nelson WW, Gurwitz JH, Lafata JE, Davis RL, Feldstein A, Raebel MA. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc. 2005 Dec; 53(12):2165-9. PMID: 16398903.
      View in: PubMed
    120. Raebel MA, Lyons EE, Andrade SE, Chan KA, Chester EA, Davis RL, Ellis JL, Feldstein A, Gunter MJ, Lafata JE, Long CL, Magid DJ, Selby JV, Simon SR, Platt R. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med. 2005 Dec; 20(12):1120-6. PMID: 16423101; PMCID: PMC1490279.
    121. Raebel MA, Ellis JL, Andrade SE. Evaluation of gestational age and admission date assumptions used to determine prenatal drug exposure from administrative data. Pharmacoepidemiol Drug Saf. 2005 Dec; 14(12):829-36. PMID: 15800957.
      View in: PubMed
    122. Raebel MA, Lyons EE, Chester EA, Bodily MA, Kelleher JA, Long CL, Miller C, Magid DJ. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial. Arch Intern Med. 2005 Nov 14; 165(20):2395-401. PMID: 16287769.
      View in: PubMed
    123. Raebel MA, Witt DM, Carroll NM, Magid DJ. Warfarin monitoring in ambulatory older individuals receiving antimicrobial therapy. Pharmacotherapy. 2005 Aug; 25(8):1055-61. PMID: 16207095.
      View in: PubMed
    124. Malone DC, Raebel MA, Porter JA, Lanty FA, Conner DA, Gay EC, Merenich JA, Vogel EA. Cost-effectiveness of sibutramine in the LOSE Weight Study: evaluating the role of pharmacologic weight-loss therapy within a weight management program. J Manag Care Pharm. 2005 Jul-Aug; 11(6):458-68. PMID: 15998163.
      View in: PubMed
    125. Raebel MA. Interventions to improve treatment of respiratory infections in ambulatory managed-care patients. Ann Pharmacother. 2005 Apr; 39(4):699-705. PMID: 15741412.
      View in: PubMed
    126. Stille CJ, Andrade SE, Huang SS, Nordin J, Raebel MA, Go AS, Chan KA, Finkelstein JA. Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics. 2004 Nov; 114(5):1206-11. PMID: 15520097.
      View in: PubMed
    127. Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA. Health services use and health care costs of obese and nonobese individuals. Arch Intern Med. 2004 Oct 25; 164(19):2135-40. PMID: 15505127.
      View in: PubMed
    128. Calis KA, Hutchison LC, Elliott ME, Ives TJ, Zillich AJ, Poirier T, Townsend KA, Woodall B, Feldman S, Raebel MA. Healthy People 2010: challenges, opportunities, and a call to action for America's pharmacists. Pharmacotherapy. 2004 Sep; 24(9):1241-94. PMID: 15460187.
      View in: PubMed
    129. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004 Aug; 191(2):398-407. PMID: 15343213.
      View in: PubMed
    130. Porter JA, Raebel MA, Conner DA, Lanty FA, Vogel EA, Gay EC, Merenich JA. The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization. Am J Manag Care. 2004 Jun; 10(6):369-76. PMID: 15209480.
      View in: PubMed
    131. Long CL, Raebel MA, Price DW, Magid DJ. Compliance with dosing guidelines in patients with chronic kidney disease. Ann Pharmacother. 2004 May; 38(5):853-8. PMID: 15054147.
      View in: PubMed
    132. McConnell KJ, Humphries TL, Raebel MA, Merenich JA. Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus. Pharmacotherapy. 2003 Dec; 23(12):1564-72. PMID: 14695037.
      View in: PubMed
    133. Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, Go AS, Smith D, Johnson CC, Kleinman K, Chan KA, Platt R. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003 Sep; 112(3 Pt 1):620-7. PMID: 12949293.
      View in: PubMed
    134. Kelleher JA, Raebel MA. Meningococcal vaccine use in college students. Ann Pharmacother. 2002 Nov; 36(11):1776-84. PMID: 12398576.
      View in: PubMed
    135. Putnam KG, Buist DS, Fishman P, Andrade SE, Boles M, Chase GA, Goodman MJ, Gurwitz JH, Platt R, Raebel MA, Arnold Chan K. Chronic disease score as a predictor of hospitalization. Epidemiology. 2002 May; 13(3):340-6. PMID: 11964937.
      View in: PubMed
    136. Platt R, Davis R, Finkelstein J, Go AS, Gurwitz JH, Roblin D, Soumerai S, Ross-Degnan D, Andrade S, Goodman MJ, Martinson B, Raebel MA, Smith D, Ulcickas-Yood M, Chan KA. Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf. 2001 Aug-Sep; 10(5):373-7. PMID: 11802579.
      View in: PubMed
    137. McNicholl IR, Raebel MA. Malaria epidemiology and economics in a pharmacist-managed international travel clinic. Pharmacotherapy. 1999 Dec; 19(12):1363-8. PMID: 10600084.
      View in: PubMed
    138. Raebel MA, Ou BS. Rotavirus disease and its prevention in infants and children. Pharmacotherapy. 1999 Nov; 19(11):1279-95. PMID: 10555934.
      View in: PubMed
    139. Davis DD, Raebel MA. Ambulatory management of chemotherapy-induced fever and neutropenia in adult cancer patients. Ann Pharmacother. 1998 Dec; 32(12):1317-23. PMID: 9876814.
      View in: PubMed
    140. Conboy K, Welage LS, Walawander CA, Duffy LC, Welliver RC, Zielezny MA, DiPiro JT, Raebel MA, Grasela TH. Sepsis syndrome and associated sequelae in patients at high risk for gram-negative sepsis. Pharmacotherapy. 1995 Jan-Feb; 15(1):66-77. PMID: 7739948.
      View in: PubMed
    141. Grasela TH, Goodwin SD, Pasko MT, Walawander CA, Raebel MA. Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole. Ann Pharmacother. 1994 Feb; 28(2):252-60. PMID: 8173147.
      View in: PubMed
    142. Clem JR, Havemann DF, Raebel MA. Insect repellent (N,N-diethyl-m-toluamide) cardiovascular toxicity in an adult. Ann Pharmacother. 1993 Mar; 27(3):289-93. PMID: 8453162.
      View in: PubMed
    143. Raebel MA, Browne BA. Clindamycin, erythromycin, and the newer macrolides. Clin Podiatr Med Surg. 1992 Apr; 9(2):409-23. PMID: 1586909.
      View in: PubMed
    144. Appleton MP, Kuehl TJ, Raebel MA, Adams HR, Knight AB, Gold WR. Magnesium sulfate versus phenytoin for seizure prophylaxis in pregnancy-induced hypertension. Am J Obstet Gynecol. 1991 Oct; 165(4 Pt 1):907-13. PMID: 1951552.
      View in: PubMed
    145. Rynearson RR, Raebel MA, Engvall WR, Spiekerman MA, Hillis A, Gross D. Effect of Monoamine Oxidase Inhibition, Thiopental Anesthesia, and Electroconvulsive Shock (ECS). Convuls Ther. 1990; 6(2):153-159. PMID: 11941057.
      View in: PubMed
    146. Copeland CA, Raebel MA, Wagner SL. Pesticide residue in lanolin. JAMA. 1989 Jan 13; 261(2):242. PMID: 2909014.
      View in: PubMed
    147. Grasela TH, Edwards BA, Raebel MA, Sisca TS, Zarowitz BJ, Schentag JJ. A clinical pharmacy-oriented drug surveillance network: II. Results of a pilot project. Drug Intell Clin Pharm. 1987 Nov; 21(11):909-14. PMID: 3678066.
      View in: PubMed
    148. Raebel MA, McDonald JB. Twenty-four-hour single-container system for parenteral nutrient admixtures. Am J Hosp Pharm. 1985 Jun; 42(6):1355-8. PMID: 3925769.
      View in: PubMed
    149. Haas JD, Raebel MA. Cephapirin interference with urine-glucose testing systems. Am J Hosp Pharm. 1984 Jun; 41(6):1186-7. PMID: 6741966.
      View in: PubMed
    150. Raebel MA. Nonequivalence of phenytoin capsules and tablets. N Engl J Med. 1983 Oct 13; 309(15):925. PMID: 6888489.
      View in: PubMed
    151. Howard PH, Raebel M, Hurley DL. The use of antimicrobial agents in patients with hepatic and renal dysfunction. Surg Clin North Am. 1982 Apr; 62(2):333-40. PMID: 7071698.
      View in: PubMed
    152. Bradberry JC, Raebel MA. Continuous infusion of naloxone in the treatment of narcotic overdose. Drug Intell Clin Pharm. 1981 Dec; 15(12):945-50. PMID: 7338189.
      View in: PubMed
    153. Waller ES, Raebel MA. Relapsing polychondritis in a Latin American man. Am J Hosp Pharm. 1979 Jun; 36(6):806-10. PMID: 463901.
      View in: PubMed
    Raebel's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2018 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.